Commentary Outrage of the Month: Dangerous New Opioid Pain Drug Scheduled to Hit U.S. Market in March March 1, 2014
Commentary Outrage of the Month: FDAs Reckless Inaction Regarding Over-the-Counter Acetaminophen February 1, 2014
Commentary Commentary in The New York Times “Room for Debate” Series on Trying Newly Approved Medications November 18, 2013